Adelaide Research & Scholarship: Browsing DSpace

Browsing "Pharmacology" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 575 to 594 of 918 < previous next >

Issue Date	Title	Author(s)
2006	One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)	Teesson, M.; Ross, J.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R.
2005	Opening the nasal valve with external dilators reduces congestive symptoms in normal subjects	Latte, J.; Taverner, David
2012	Opioid activation of toll-like receptor 4 contributes to drug reinforcement	Hutchinson, M.; Northcutt, A.; Hiranita, T.; Wang, X.; Lewis, S.; Thomas, J.; van Steeg, K.; Kopajtic, T.; Loram, L.; Sfregola, C.; Galer, E.; Miles, N.; Bland, S.; Amat, J.; Rozeske, R.; Maslanik, T.; Chapman, T.; Strand, K.; Fleshner, M.; Bachtell, R.; et al.
2000	Opioid antagonists and adrenergic agonists for the management of opioid withdrawal	Gowing, L.; Ali, R.; White, J.
2010	Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal	Gowing, L.; Ali, R.; White, J.
2006	Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal (review)	Gowing, L.; Ali, R.; White, J.
2009	Opioid antagonists with minimal sedation for opioid withdrawal	Gowing, L.; Ali, R.; White, J.; Gowing, L.
2006	Opioid antagonists with minimal sedation for opioid withdrawal (review)	Gowing, L.; Ali, R.; White, J.; Gowing, L.
2003	Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine	Lopatko, O.; White, J.; Huber, A.; Ling, W.
2007	Opioid maintenance: a comparative review of pharmacological strategies	White, J.; Lopatko, O.
2015	Opioid-induced central immune signaling: implications for opioid analgesia	Grace, P.M.; Maier, S.F.; Watkins, L.R.
2019	Opioids and matrix metalloproteinases: the influence of morphine on MMP-9 production and cancer progression	Khabbazi, S.; Hassanshahi, M.; Hassanshahi, A.; Peymanfar, Y.; Su, Y.W.; Xian, C.J.
2007	Opioids, pain and addiction: Cause and consequence	White, J.; Hay, J.; Miller, P.; Kavanagh, D.
2004	Optimisation of the comet genotoxicity assay in freshly isolated murine hepatocytes: detection of strong in vitro DNA damaging properties for styrene	Fontaine, F.; DeGraaf, Y.; Ghaoui, R.; Sallustio, B.; Edwards, J.; Burcham, P.
1999	Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning?	Buckley, Nicholas A.; Whyte, Ian M.; O'Connell, Dianne; Dawson, Andrew H.
2011	Oral substitution treatment of injecting opioid users for prevention of HIV infection (Review)	Gowing, L.; Farrell, M.; Bornemann, R.; Sullivan, L.; Ali, R.
2003	Oral toxicity of the cyanobacterial toxin cylindrospermopsin in male Swiss albino mice: Determination of no observed adverse effect level for deriving a drinking water guideline value	Humpage, A.; Falconer, I.
2004	Orbital myositis in Churg-Strauss syndrome	Billing, K.; Malhotra, R.; Selva-Nayagam, D.; Dodd, T.
2008	Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice	Baganz, N.; Horton, R.; Calderon, A.; Owens, W.; Munn, J.; Watts, L.; Koldzic-Zivanovic, N.; Jeske, N.; Koek, W.; Toney, G.; Daws, L.
2000	Organophosphate poisoning versus brainstem stroke	Beare, C.; Buckley, N.

Showing results 575 to 594 of 918 < previous next >